Kips Bay Medical, Inc.  

(Public, NASDAQ:KIPS)   Watch this stock  
Find more results for kips
0.405
-0.019 (-4.41%)
Real-time:   9:33AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.41 - 0.41
52 week 0.40 - 0.99
Open 0.41
Vol / Avg. 0.00/87,369.00
Mkt cap 13.37M
P/E     -
Div/yield     -
EPS -0.22
Shares 33.01M
Beta 2.75
Inst. own 6%
Aug 12, 2014
Q2 2014 Kips Bay Medical Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -5526.92% -4661.54%
Operating margin -5534.61% -4673.85%
EBITD margin - -4631.54%
Return on average assets -76.61% -66.72%
Return on average equity -82.13% -71.62%
Employees 14 -
CDP Score - -

Address

3405 ANNAPOLIS LANE
MINNEAPOLIS, MN 55447
United States - Map
+1-763-2353540 (Phone)
+1-763-2353545 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Kips Bay Medical, Inc. is a medical device company focused on developing, manufacturing and commercializing its external saphenous vein support technology (eSVS MESH) for use in coronary artery bypass grafting (CABG) surgery. The Company�s eSVS MESH is a nitinol mesh sleeve that, when placed over a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and performance of the vein graft. The eSVS MESH is a kink-resistant extravascular tubular prosthesis made of knitted nickel/titanium, or nitinol, wire mesh.

Officers and directors

Manuel A. Villafana Chairman of the Board, Chief Executive Officer
Age: 74
Bio & Compensation  - Reuters
Scott Kellen Chief Financial Officer, Chief Operating Officer, Vice President - Finance, Secretary
Age: 48
Bio & Compensation  - Reuters
Randall Keith LaBounty Vice President - Regulatory and Clinical Affairs
Age: 51
Bio & Compensation  - Reuters
Robert E. Munzenrider CPA Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Robert J. Sheehy Independent Director
Age: 56
Bio & Compensation  - Reuters
Arch C. Smith Independent Director
Bio & Compensation  - Reuters